143 related articles for article (PubMed ID: 8617118)
1. Bioavailability and efficacy of omeprazole given orally and by nasogastric tube.
Larson C; Cavuto NJ; Flockhart DA; Weinberg RB
Dig Dis Sci; 1996 Mar; 41(3):475-9. PubMed ID: 8617118
[TBL] [Abstract][Full Text] [Related]
2. The bioavailability of bromazepam, omeprazole and paracetamol given by nasogastric feeding tube.
Podilsky G; Berger-Gryllaki M; Testa B; Buclin T; Roulet M; Pannatier A
Eur J Clin Pharmacol; 2009 May; 65(5):435-42. PubMed ID: 19189088
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics during treatment with the omeprazole 20 mg enteric-coated tablet and 20 mg capsule in asymptomatic duodenal ulcer patients.
Thomson AB; Kirdeikis P; Lastiwka R; Röhss K; Sinclair P; Olofsson B
Can J Gastroenterol; 1997; 11(8):657-60. PubMed ID: 9459044
[TBL] [Abstract][Full Text] [Related]
4. Influence of food on the bioavailability of an enteric-coated tablet formulation of omeprazole 20 mg under repeated dose conditions.
Thomson AB; Sinclair P; Matisko A; Rosen E; Andersson T; Olofsson B
Can J Gastroenterol; 1997; 11(8):663-7. PubMed ID: 9459045
[TBL] [Abstract][Full Text] [Related]
5. Lansoprazole: administration of the contents of a capsule dosage formulation through a nasogastric tube.
Chun AH; Shi HH; Achari R; Dennis S; Cavanaugh JH
Clin Ther; 1996; 18(5):833-42. PubMed ID: 8930427
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability of omeprazole 20 mg capsules containing omeprazole 22.5% enteric coated pellets versus a reference product in healthy Bangladeshi male subjects: an open-label, single-dose, randomized-sequence, two-way crossover study.
Islam MS; Trini AB; Shohag H; Ahmed MU; Maruf AA; Hasnat A
Int J Clin Pharmacol Ther; 2011 Dec; 49(12):778-86. PubMed ID: 22122821
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and absolute bioavailability of lansoprazole.
Gerloff J; Mignot A; Barth H; Heintze K
Eur J Clin Pharmacol; 1996; 50(4):293-7. PubMed ID: 8803522
[TBL] [Abstract][Full Text] [Related]
8. Effects of orally administered enteric-coated omeprazole on gastric acid secretion in horses.
Andrews FM; Doherty TJ; Blackford JT; Nadeau JA; Saxton AM
Am J Vet Res; 1999 Aug; 60(8):929-31. PubMed ID: 10451198
[TBL] [Abstract][Full Text] [Related]
9. A randomized, pharmacokinetic and pharmacodynamic, cross-over study of duodenal or jejunal administration compared to nasogastric administration of omeprazole suspension in patients at risk for stress ulcers.
Phillips JO; Olsen KM; Rebuck JA; Rangnekar NJ; Miedema BW; Metzler MH
Am J Gastroenterol; 2001 Feb; 96(2):367-72. PubMed ID: 11232677
[TBL] [Abstract][Full Text] [Related]
10. Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg) or enteric-coated aspirin 325 mg + enteric-coated omeprazole 40 mg - a randomised, phase 1, crossover study.
Miner PB; Fort JG; Zhang Y
Aliment Pharmacol Ther; 2013 Jul; 38(1):62-71. PubMed ID: 23692061
[TBL] [Abstract][Full Text] [Related]
11. Comparative pharmacokinetics and pharmacodynamics of lansoprazole oral capsules and suspension in healthy subjects.
Doan TT; Wang Q; Griffin JS; Lukasik NL; O'Dea RF; Pan WJ
Am J Health Syst Pharm; 2001 Aug; 58(16):1512-9. PubMed ID: 11515348
[TBL] [Abstract][Full Text] [Related]
12. Bioavailability of lansoprazole granules administered in juice or soft food compared with the intact capsule formulation.
Chun AH; Erdman K; Chiu YL; Pilmer BL; Achari R; Cavanaugh JH
Clin Ther; 2002 Aug; 24(8):1322-31. PubMed ID: 12240782
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole.
Andersson T; Röhss K; Bredberg E; Hassan-Alin M
Aliment Pharmacol Ther; 2001 Oct; 15(10):1563-9. PubMed ID: 11563995
[TBL] [Abstract][Full Text] [Related]
14. Relative bioavailability and pharmacokinetic study of omeprazole 20 mg enteric-coated tablet in healthy Bangladeshi volunteers.
Hasan A; Abul Kalam Azad M; Ullah MA; Mahbub Latif AH; Hasnat A
Int J Clin Pharmacol Ther; 2009 Mar; 47(3):215-21. PubMed ID: 19281731
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of oral omeprazole in llamas.
Poulsen KP; Smith GW; Davis JL; Papich MG
J Vet Pharmacol Ther; 2005 Dec; 28(6):539-43. PubMed ID: 16343286
[TBL] [Abstract][Full Text] [Related]
16. A novel option in proton pump inhibitor dosing: lansoprazole orally disintegrating tablet dispersed in water and administered via nasogastric tube.
Freston JW; Kukulka MJ; Lloyd E; Lee C
Aliment Pharmacol Ther; 2004 Aug; 20(4):407-11. PubMed ID: 15298634
[TBL] [Abstract][Full Text] [Related]
17. Relative bioavailability and pharmacokinetic comparison of two different enteric formulations of omeprazole.
Liu J; Shentu JZ; Wu LH; Dou J; Xu QY; Zhou HL; Wu GL; Huang MZ; Hu XJ; Chen JC
J Zhejiang Univ Sci B; 2012 May; 13(5):348-55. PubMed ID: 22556172
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of intravenous, plain oral and enteric-coated oral omeprazole in the horse.
Sykes BW; Underwood C; McGowan CM; Mills PC
J Vet Pharmacol Ther; 2015 Apr; 38(2):130-6. PubMed ID: 25271390
[TBL] [Abstract][Full Text] [Related]
19. Relative bioavailability of single doses of prolonged-release tacrolimus administered as a suspension, orally or via a nasogastric tube, compared with intact capsules: a phase 1 study in healthy participants.
Undre N; Dickinson J
BMJ Open; 2017 Apr; 7(4):e012252. PubMed ID: 28377389
[TBL] [Abstract][Full Text] [Related]
20. Effective gastric acid suppression after oral administration of enteric-coated omeprazole granules.
Mohiuddin MA; Pursnani KG; Katzka DA; Gideon RM; Castell JA; Castell DO
Dig Dis Sci; 1997 Apr; 42(4):715-9. PubMed ID: 9125637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
